Since the beginning of October 2009, over 350 YAZ®, Yasmin® and Ocella® cases from various jurisdictions throughout the country have been transferred to the MDL in the United States District Court for the Southern District of Illinois. On November 9, 2009, motions were filed to appoint Plaintiffs’ lead counsel and a Plaintiffs’ Steering Committee. The Court will hold a conference in the coming weeks to address the newly transferred cases and pending motions.
Home > Defective Drugs > YAZ®, Yasmin® and Ocella® Cases Transfered to MDL in the United States Distric Court
Topics
Authors
Kevin M. Hart
Shareholder
Kevin is the Chairman and Senior Litigation Counsel of the Stark & Stark Mass Tort Litigation Group. Mr. Hart has over 30 years of experience as a trial attorney.
Craig S. Hilliard
Shareholder
Craig is a Shareholder and member of the Stark & Stark Mass Tort Litigation Group. Mr. Hilliard has extensive experience prosecuting and defending class actions involving securities and consumer fraud claims.
Martin P. Schrama
Shareholder
Martin is a Shareholder and member of the Stark & Stark Mass Tort Litigation Group. Mr. Schrama has extensive experience prosecuting and defending class actions involving securities, employment and consumer fraud claims.
Stefanie Colella-Walsh
Associate
Stefanie is an Associate and member of the Stark & Stark Mass Tort Litigation Group where she concentrates her practice in complex litigation with a focus in mass tort and pharmaceutical litigation.
Contact
How can we help? Any information you provide is considered confidential and will not be shared outside of our firm.

